UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dopamine regulates adult neurogenesis in the ventricular‐subventricular zone via dopamine D3 angiotensin type 2 receptor interactions

Stem cells (Dayton, Ohio), 2021-12, Vol.39 (12), p.1778-1794

2021

Volltextzugriff (PDF)

DOPAMINE INCREASE ADULT NEUROGENESIS IN THE VENTRICULAR-SUBVENTRICULAR ZONE VIA DOPAMINE D3 RECEPTORS AND RECIPROCAL INTERACTIONS WITH ANGIOTENSIN TYPE 2 RECEPTOR

IBRO neuroscience reports, 2023-10, Vol.15, p.S196-S196

2023

Volltextzugriff (PDF)

Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19

Clinical science (1979), 2021-02, Vol.135 (3), p.465-481

2021

Volltextzugriff (PDF)

Chronic and progressive Parkinson's disease MPTP model in adult and aged mice

Journal of neurochemistry, 2016-01, Vol.136 (2), p.373-387

2016

Volltextzugriff (PDF)

Interactions between ibuprofen, ACE2, renin‐angiotensin system, and spike protein in the lung. Implications for COVID‐19

Clinical and translational medicine, 2021-04, Vol.11 (4), p.e371-n/a

2021

Volltextzugriff (PDF)

Parkinson's disease and diabetes mellitus: common mechanisms and treatment repurposing

Neural regeneration research, 2022-08, Vol.17 (8), p.1652-1658

2022

Volltextzugriff (PDF)

Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease

NPJ Parkinson's Disease, 2022-06, Vol.8 (1), p.76-76, Article 76

2022

Volltextzugriff (PDF)

Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration

Frontiers in aging neuroscience, 2017-05, Vol.9, p.129-129

2017

Volltextzugriff (PDF)

Microglial angiotensin type 2 receptors mediate sex‐specific expression of inflammatory cytokines independently of circulating estrogen

Glia, 2022-12, Vol.70 (12), p.2348-2360

2022

Volltextzugriff (PDF)

Brain renin-angiotensin system and dopaminergic cell vulnerability

Frontiers in neuroanatomy, 2014-07, Vol.8, p.67

2014

Volltextzugriff (PDF)

NSGA-II based short-term building energy management using optimal LSTM-MLP forecasts

International journal of electrical power & energy systems, 2024-08, Vol.159, p.110070, Article 110070

2024

Volltextzugriff (PDF)

Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models

Molecular neurobiology, 2018-09, Vol.55 (9), p.7297-7316

2018

Volltextzugriff (PDF)

Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans

Molecular neurobiology, 2018-07, Vol.55 (7), p.5847-5867

2018

Volltextzugriff (PDF)

Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration

Cell death & disease, 2016-10, Vol.7 (10), p.e2427-e2427

2016

Volltextzugriff (PDF)

Aqueous Three-Component Self-Assembly of a Pseudo[1]rotaxane Using Hydrazone Bonds

Journal of organic chemistry, 2023-06, Vol.88 (11), p.6784-6790

2023

Volltextzugriff (PDF)

Astrocytic insulin receptor controls circadian behavior via dopamine signaling in a sexually dimorphic manner

Nature communications, 2023-12, Vol.14 (1), p.8175-8175, Article 8175

2023

Volltextzugriff (PDF)

Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease

Journal of neuroinflammation, 2012-02, Vol.9 (1), p.38-38, Article 38

2012

Volltextzugriff (PDF)

Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra

Brain, behavior, and immunity, 2020-07, Vol.87, p.256-271

2020

Volltextzugriff (PDF)

Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging

Oncotarget, 2016-05, Vol.7 (21), p.30049-30067

2016

Volltextzugriff (PDF)

Central nicotine induces browning through hypothalamic κ opioid receptor

Nature communications, 2019-09, Vol.10 (1), p.4037-12, Article 4037

2019

Volltextzugriff (PDF)

Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β

Experimental neurology, 2014-11, Vol.261, p.720-732

2014

Volltextzugriff (PDF)

Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death

Neurotherapeutics, 2018-10, Vol.15 (4), p.1063-1081

2018

Volltextzugriff (PDF)

inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease

Journal of neurochemistry, 2009-04, Vol.109 (2), p.656-669

2009

Volltextzugriff (PDF)

An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria

Redox biology, 2021-10, Vol.46, p.102078-102078, Article 102078

2021

Volltextzugriff (PDF)

Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells

Experimental neurology, 2013-12, Vol.250, p.384-396

2013

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(59)

Publikationsform

Artikel
(60)
Buchkapitel
(1)

Sprache

Englisch
(60)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dopamine regulates adult neurogenesis in the ventricular‐subventricular zone via dopamine D3 angiotensin type 2 receptor interactions

DOPAMINE INCREASE ADULT NEUROGENESIS IN THE VENTRICULAR-SUBVENTRICULAR ZONE VIA DOPAMINE D3 RECEPTORS AND RECIPROCAL INTERACTIONS WITH ANGIOTENSIN TYPE 2 RECEPTOR

Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19

Chronic and progressive Parkinson's disease MPTP model in adult and aged mice

Interactions between ibuprofen, ACE2, renin‐angiotensin system, and spike protein in the lung. Implications for COVID‐19

Parkinson's disease and diabetes mellitus: common mechanisms and treatment repurposing

Angiotensin type-1 receptor and ACE2 autoantibodies in Parkinson´s disease

Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration

Microglial angiotensin type 2 receptors mediate sex‐specific expression of inflammatory cytokines independently of circulating estrogen

Brain renin-angiotensin system and dopaminergic cell vulnerability

NSGA-II based short-term building energy management using optimal LSTM-MLP forecasts

Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson’s Disease Models

Paracrine and Intracrine Angiotensin 1-7/Mas Receptor Axis in the Substantia Nigra of Rodents, Monkeys, and Humans

Mitochondrial angiotensin receptors in dopaminergic neurons. Role in cell protection and aging-related vulnerability to neurodegeneration

Aqueous Three-Component Self-Assembly of a Pseudo[1]rotaxane Using Hydrazone Bonds

Astrocytic insulin receptor controls circadian behavior via dopamine signaling in a sexually dimorphic manner

Involvement of PPAR-γ in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson's disease

Angiotensin type 2 receptors: Role in aging and neuroinflammation in the substantia nigra

Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging

Central nicotine induces browning through hypothalamic κ opioid receptor

Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β

Angiotensin Type 1 Receptor Antagonists Protect Against Alpha-Synuclein-Induced Neuroinflammation and Dopaminergic Neuron Death

inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease

An ACE2/Mas-related receptor MrgE axis in dopaminergic neuron mitochondria

Brain angiotensin regulates iron homeostasis in dopaminergic neurons and microglial cells

Suchergebnisse filtern